相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TERT promoter mutations associate with fast-growing melanoma
Eduardo Nagore et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
Josh Lewis Stern et al.
GENES & DEVELOPMENT (2015)
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
Ismail Hosen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
Seung Soo Yoo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Yinghui Li et al.
NATURE CELL BIOLOGY (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Frequency of TERT Promoter Mutations in Prostate Cancer
Robert Stoehr et al.
PATHOBIOLOGY (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
Elisabetta Macerola et al.
VIRCHOWS ARCHIV (2015)
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
Mohamed Ali Mosrati et al.
ONCOTARGET (2015)
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Kunitoshi Chiba et al.
ELIFE (2015)
TERT promoter mutations in clear cell renal cell carcinoma
Ismail Hosen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
Matthias Simon et al.
NEURO-ONCOLOGY (2015)
TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population
Alexandra S. Shadrina et al.
TUMOR BIOLOGY (2015)
TERT promoter mutations in cancer development
Barbara Heidenreich et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
Helena Populo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
Klaus G. Griewank et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm
Iraz T. Aydin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Recurrent TERT promoter mutations in non-small cell lung cancers
Xiao Ma et al.
LUNG CANCER (2014)
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
Barbara Heidenreich et al.
NATURE COMMUNICATIONS (2014)
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Georgina V. Long et al.
NATURE COMMUNICATIONS (2014)
The Evolution of Melanoma Resistance Reveals Therapeutic Opportunities
Meghna Das Thakur et al.
CANCER RESEARCH (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Jared J. Gartner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
Zhihu Ding et al.
CELL (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Melanoma: from mutations to medicine
Hensin Tsao et al.
GENES & DEVELOPMENT (2012)
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
Mitchell S. Stark et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
From genes to drugs: targeted strategies for melanoma
Keith T. Flaherty et al.
NATURE REVIEWS CANCER (2012)
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Xiaomu Wei et al.
NATURE GENETICS (2011)
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc
Dakang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Genes and pathways downstream of telomerase in melanoma metastasis
Sepideh Bagheri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter -: effect on telomerase expression and telomere length maintenance in non-small cell lung cancer
Chung-Ping Hsu et al.
EUROPEAN JOURNAL OF CANCER (2006)
分享论文
